A reduced oxidative capacity in skeletal muscle from T2D individuals [11, 12], and in lean, insulin resistant offspring of T2D patients [13] has been found, supporting the hypothesis that IR in skeletal muscle is associated with dysregulation of intramyocellular fatty acid metabolism. The gene discussed is INS; the disease is type 2 diabetes mellitus.